Intraocular Melanoma Completed Phase 1 / 2 Trials for Aldesleukin (DB00041)

Also known as: Intraocular melanoma NOS

IndicationStatusPhase
DBCOND0028574 (Intraocular Melanoma)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00058279Monoclonal Antibody Therapy and Interleukin-2 in Treating Patients With Metastatic MelanomaTreatment